NARA Discovery
Article Details
← Back to Search Results
Journal Article

Synthesis and In vitro cytotoxic activity evaluation of (E)-16-(substituted benzylidene) derivatives of dehydroepiandrosterone

Mohsen Vosooghi; Hoda Yahyavi; Kouros Divsalar; Hashem Shamsa; Asma Kheirollahi; Maliheh Safavi; Sussan Kabudanian Ardestani; Sareh Sadeghi-Neshat; Negar Mohammadhosseini; Najmeh Edraki; Mehdi Khoshneviszadeh; Abbas Shafiee; Alireza Foroumadi
DARU Journal of Pharmaceutical Sciences · Vol. 21, Issue 1 · 2013

Abstract

Background and the purpose of the study Modified androsterone derivatives are class of steroidal compounds with potential anticancer properties. Various steroidal derivatives containing substitution at position 16 have shown diversified pharmacological activities. In the present study, a new series of cytotoxic 16-(substituted benzylidene) derivatives of dehydroepiandrosterone (DHEA) were synthesized and evaluated against three different cancer cell lines. Methods The cytotoxic 16-(substituted benzylidene) derivatives of DHEA were synthesized via aldol condensation of DHEA with corresponding benzaldehyde derivatives. The cytotoxic activity of synthesized derivatives was evaluated against three different cancer cells including KB, T47D and SK-N-MC cell lines by MTT reduction colorimetric assay. Results The results indicated that 16-(substituted benzylidene) derivatives of DHEA could be served as a potent anti-cancer agent. The 3-cholro benzylidene derivatives of DHEA was the most potent synthesized derivative especially against KB and T47D cell lines (IC 50 values were 0.6 and 1.7 μM; respectively). Conclusion The cytotoxic potential of novel benzylidene derivatives of DHEA is mainly attributed to the position and nature of the substituted group on the benzylidene pendant.

Bibliographic Information

JournalDARU Journal of Pharmaceutical Sciences
PublisherSpringer
Publication Date2013-12-01
Publication Year2013
Volume21
Issue1
Document TypeJournal Article
eISSN2008-2231
DOI10.1186/2008-2231-21-34

Access Information

NARA Access Coverage2012-01-01~Current
Journal Homepagehttps://www.springer.com/journal/40199
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.